Chronic Kidney Disease Trial, Recruiting (NCT03573089)

Chronic Kidney Disease Trial, Recruiting NCT03573089 Sponsor: The University of Queensland Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT03573089 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 45 years old or older, OR you are 18 years old or older and have diabetes
Your kidneys have permanently stopped working and you are receiving dialysis (either haemodialysis or peritoneal dialysis) and have been on dialysis for at least 3 months
You are currently taking at least one medication to help lower the phosphate levels in your blood
You are able to understand the study and give your consent to take part

Who may not be able to join:

You have a kidney transplant already planned and scheduled
Your doctor believes that a serious illness or health condition you currently have may be life-threatening within the next 6 months
You are already taking part in another clinical trial that could affect the phosphate levels in your blood

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sunil Badve, The University of Queensland

Phone: 416 867 3703

Australian sites

Royal Prince Alfred Hosptial, Camperdown, New South Wales

Nepean Hospital, Kingswood, New South Wales

St George Hospital, Kogarah, New South Wales

Royal North Shore Hospital, Saint Leonards, New South Wales

Western Sydney Renal Service, Westmead, New South Wales

Wollongong Hospital, Wollongong, New South Wales

Sunshine Coast University Hospital, Birtinya, Queensland

Royal Brisbane and Women's Hospital, Brisbane, Queensland

Princess Alexandra Hospital, Brisbane, Queensland

Bundaberg Hospital, Bundaberg, Queensland

Cairns Hospital, Cairns, Queensland

Fraser Coast Renal Service, Hervey Bay, Queensland

Mackay Hospital, Mackay, Queensland

Logan Hospital, Meadowbrook, Queensland

Gold Coast University Hospital, Southport, Queensland

Townsville University Hospital, Townsville, Queensland

Central and Northern Adelaide Renal and Transplant Service, Adelaide, South Australia

Flinders Medical Centre, Bedford Park, South Australia

Austin Health, Heidelberg, Victoria

Royal Melbourne Hospital, Melbourne, Victoria

St Vincent's Hospital Melbourne, Melbourne, Victoria

Latrobe Regional Hospital, Traralgon, Victoria

Armadale Hospital, Armadale, Washington

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03573089

Sponsor: The University of Queensland

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 416 867 3703

More information: https://clinicaltrials.gov/study/NCT03573089

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 45 years old or older, OR you are 18 years old or older and have diabetes
Your kidneys have permanently stopped working and you are receiving dialysis (either haemodialysis or peritoneal dialysis) and have been on dialysis for at least 3 months
You are currently taking at least one medication to help lower the phosphate levels in your blood
You are able to understand the study and give your consent to take part

Who may not be able to join:

You have a kidney transplant already planned and scheduled
Your doctor believes that a serious illness or health condition you currently have may be life-threatening within the next 6 months
You are already taking part in another clinical trial that could affect the phosphate levels in your blood

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Queensland

Registry

ClinicalTrials.gov

Start date

10 December 2019

Est. completion

31 December 2027

Where this trial is recruiting

🇦🇺 Australia 🇧🇷 Brazil 🇨🇦 Canada 🇫🇷 France 🇮🇱 Israel 🇳🇿 New Zealand 🇹🇭 Thailand 🇬🇧 United Kingdom

23 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Time to a composite endpoint of cardiovascular death or non-fatal major cardiovascular event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov